The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Prognostic Significance of Activated Akt Expression in Melanoma: A Clinicopathologic Study of 292 Cases
Abstract
Purpose: Akt is a serine/threonine kinase that leads to stimulation of cell cycle progression, cell proliferation, and inhibition of apoptosis. To investigate the role of Akt in melanoma pathogenesis, we examined the expression of phospho-Akt (p-Akt; Ser-473) in melanocytic lesions at different stages and analyzed the correlations between the p-Akt expression level and clinicopathologic factors and patient survival. Patients and Methods: We evaluated the p-Akt expression in 12 cases of normal nevi, 58 cases of dysplastic nevi, 170 cases of primary melanomas, and 52 cases of melanoma metastases using tissue microarray and immunohistochemistry. Results: Strong p-Akt expression was observed in 17%, 43%, 49%, and 77% of the biopsies in normal nevi, dysplastic nevi, primary melanoma, and melanoma metastases, respectively. Significant differences for p-Akt staining pattern were observed between normal nevi and primary melanomas (P < .05), and between primary melanomas and melanoma metastases (P < .001). Furthermore, our Kaplan-Meier survival curves showed that strong p-Akt expression is inversely correlated with both overall and disease-specific 5-year survival of patients with primary melanoma (P < .05 for both). Strikingly, our multivariate Cox regression analysis revealed that p-Akt is an independent prognostic factor in low-risk melanomas (thickness ≤ 1.5 mm; relative risk, 6.44; 95% CI, 1.28 to 32.55; P = .018). Conclusion: The expression of p-Akt increases dramatically with melanoma invasion and progression and is inversely correlated with patient survival. In addition, p-Akt may serve as an independent prognostic marker and help to identify those patients with low-risk melanomas who are at increased risk of death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sun, M., Yang, L., Feldman, R. I., Sun, X.-M., Bhalla, K. N., Jove, R., Nicosia, S. V., & Cheng, J. Q. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306295200 · Cited by 171
RetractedAkt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.23 · Cited by 2,917
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch, C. M., Buzaid, A. C., Soong, S.-J., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3635 · Cited by 2,636
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase
Nidai Ozes, O., Mayo, L. D., Gustin, J. A., Pfeffer, S. R., Pfeffer, L. M., & Donner, D. B. (1999) · Nature · doi:10.1038/43466 · Cited by 1,832
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,668
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,639
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436
Zhou, B. P., Liao, Y., Xia, W., Spohn, B., Lee, M.-H., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/35060032 · Cited by 1,135
Biggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116
Role of Translocation in the Activation and Function of Protein Kinase B
Andjelkovic, M., Alessi, D. R., Meier, R., Fernandez, A., Lamb, N. J. C., Frech, M., Cron, P., Cohen, P., Lucocq, J. M., & Hemmings, B. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31515 · Cited by 1,051
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
Liang, J., Zubovitz, J., Petrocelli, T., Kotchetkov, R., Connor, M. K., Han, K., Lee, J.-H., Ciarallo, S., Catzavelos, C., Beniston, R., et al. (2002) · Nature Medicine · doi:10.1038/nm761 · Cited by 948
A Retroviral Oncogene, akt , Encoding a Serine-Threonine Kinase Containing an SH2-Like Region
Bellacosa, A., Testa, J. R., Staal, S. P., & Tsichlis, P. N. (1991) · Science · doi:10.1126/science.1833819 · Cited by 939
Direct control of the Forkhead transcription factor AFX by protein kinase B
Kops, G. J. P. L., Ruiter, N. D. D., De Vries-Smits, A. M. M., Powell, D. R., Bos, J. L., & Burgering, B. M. T. (1999) · Nature · doi:10.1038/19328 · Cited by 882
The pathogenesis of melanoma induced by ultraviolet radiation
Gilchrest, B. A., Eller, M. S., Geller, A. C., & Yaar, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401707 · Cited by 876
Apoptosis and melanoma chemoresistance
Soengas, M. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206454 · Cited by 826
Cheng, J. Q., Godwin, A. K., Bellacosa, A., Taguchi, T., Franke, T. F., Hamilton, T. C., Tsichlis, P. N., & Testa, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9267 · Cited by 736
Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Akt activation by growth factors is a multiple-step process: the role of the PH domain
Bellacosa, A., Chan, T. O., Ahmed, N. N., Datta, K., Malstrom, S., Stokoe, D., McCormick, F., Feng, J., & Tsichlis, P. (1998) · Oncogene · doi:10.1038/sj.onc.1201947 · Cited by 547
Jones, P. F., Jakubowicz, T., Pitossi, F. J., Maurer, F., & Hemmings, B. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4171 · Cited by 532
COFFER, P. J., & WOODGETT, J. R. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16305.x · Cited by 487
The Emerging Epidemic of Melanoma and Squamous Cell Skin Cancer
Glass, A. G. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430150065027 · Cited by 475
Houghton, A. N., & Polsky, D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00161-7 · Cited by 414
Yang, L., Dan, H. C., Sun, M., Liu, Q., Sun, X.-M., Feldman, R. I., Hamilton, A. D., Polokoff, M., Nicosia, S. V., Herlyn, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0343 · Cited by 371
Essential Role for Protein Kinase B (PKB) in Insulin-induced Glycogen Synthase Kinase 3 Inactivation
van Weeren, P. C., de Bruyn, K. M. T., de Vries-Smits, A. M. M., van Lint, J., & Burgering, B. M. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13150 · Cited by 365
The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
Rigel, D. S., Friedman, R. J., & Kopf, A. W. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90041-9 · Cited by 345
Loss of PTEN promotes tumor development in malignant melanoma.
Stahl, J. M., Cheung, M., Sharma, A. K., Trivedi, N. R., Shanmugam, S., & Robertson, G. P. (2003) · PubMed · Cited by 310
The Akt kinase: Molecular determinants of oncogenicity
Aoki, M., Batista, O., Bellacosa, A., Tsichlis, P., & Vogt, P. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14950 · Cited by 296
Dhawan, P., Singh, A. B., Ellis, D. L., & Richmond, A. J. (2002) · PubMed · Cited by 260
Prognostic Significance of Activated Akt Expression in Pancreatic Ductal Adenocarcinoma
Yamamoto, S., Tomita, Y., Hoshida, Y., Morooka, T., Nagano, H., Dono, K., Umeshita, K., Sakon, M., Ishikawa, O., Ohigashi, H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-02-1441 · Cited by 241
Wolfrum, C., Besser, D., Luca, E., & Stoffel, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1931483100 · Cited by 209
Brodbeck, D., Cron, P., & Hemmings, B. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9133 · Cited by 204
Min, Y. H., Eom, J. I., Cheong, J. W., Maeng, H. O., Kim, J. Y., Jeung, H. K., Lee, S. T., Lee, M. H., Hahn, J. S., & Ko, Y. W. (2003) · Leukemia · doi:10.1038/sj.leu.2402874 · Cited by 192
Mutation and expression of the p53 gene in human malignant melanoma
Albino, A. P., Vidal, M. J., McNutt, N. S., Shea, C. R., Prieto, V. G., Nanus, D. M., Palmer, J. M., & Hayward, N. K. (1994) · Melanoma Research · doi:10.1097/00008390-199402000-00006 · Cited by 166
Sodhi, A., Montaner, S., Miyazaki, H., & Gutkind, J. S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5532 · Cited by 161
Molecular cloning, expression and characterization of the human serine/threonine kinase Akt‐3
Masure, S., Haefner, B., Wesselink, J., Hoefnagel, E., Mortier, E., Verhasselt, P., Tuytelaars, A., Gordon, R., & Richardson, A. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00774.x · Cited by 159
PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma
Tsao, H., Mihm, M. C., & Sheehan, C. E. (2003) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(03)02473-3 · Cited by 133
Dai, D. L., Makretsov, N. A., Campos, E. I., Huang, C., Zhou, Y., Huntsman, D. D., Martinka, M., & Li, G. (2003) · PubMed · Cited by 131
Self-citationAkt2 expression correlates with prognosis of human hepatocellular carcinoma
Xu, X., Sakon, M., Nagano, H., Hiraoka, N., Yamamoto, H., Hayashi, N., Dono, K., Nakamori, S., Umeshita, K., Ito, Y., et al. (2004) · Oncology Reports · doi:10.3892/or.11.1.25 · Cited by 121
Akt/PKB activation in gastric carcinomas correlates with clinicopathologic variables and prognosis
Nam, S. Y., Lee, H. S., Jung, G., Choi, J., Cho, S. J., Kim, M. K., Kim, W. H., & Lee, B. L. (2003) · Apmis · doi:10.1111/j.1600-0463.2003.apm1111205.x · Cited by 104
Systemic chemotherapy for the treatment of metastatic melanoma
Li, Y., & McClay, E. F. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.35237 · Cited by 104
Schmitz, K. J., Otterbach, F., Callies, R., Levkau, B., Hölscher, M., Hoffmann, O. I., Grabellus, F., Kimmig, R., Schmid, K. W., & Baba, H. A. (2003) · Modern Pathology · doi:10.1038/modpathol.3800002 · Cited by 98
Factors related to the presentation of patients with thick primary melanomas
Hersey, P., Burton, R. C., Sillar, R., Howe, C. G., Darbar, S. V., Collins, S. M., Bradley, D., Owens, D., & Foster, H. M. (1991) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1991.tb121217.x · Cited by 79
Murthy, S. S., Tosolini, A., Taguchi, T., & Testa, J. R. (2000) · Cytogenetic and Genome Research · doi:10.1159/000015481 · Cited by 78
Bedogni, B., O’Neill, M. S., Welford, S. M., Bouley, D. M., Giaccia, A. J., Denko, N. C., & Powell, M. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3327 · Cited by 78
Kosmidou, I., Xagorari, A., Roussos, C., & Papapetropoulos, A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.4.l585 · Cited by 71
Jetzt, A. E., Howe, J. A., Horn, M. T., Maxwell, E., Yin, Z., Johnson, D. E., & Kumar, C. C. (2003) · PubMed · Cited by 62
Choundhury, G. G., Kim, Y., Simon, M., Wozney, J. M., Harris, S. E., Ghosh‐Choudhury, N., & Abboud, H. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10897 · Cited by 62
Molecular Aspects of Melanocytic Dysplastic Nevi
Hussein, M. R., & Wood, G. S. (2002) · Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60684-8 · Cited by 61
Sex-related differences in neuronal cell survival and signaling in rats
Zhang, L., Li, P.-P., Feng, X., Barker, J. L., Smith, S. V., & Rubinow, D. R. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01179-5 · Cited by 61
Ragnarsson-Olding, B. K., Karsberg, S., Platz, A., & Ringborg, U. K. (2002) · Melanoma Research · doi:10.1097/00008390-200209000-00007 · Cited by 58
Melia, J., Cooper, E. J., FROST, T., GRAHAM-BROWN, R. A. C., Hunter, J. A., MARSDEN, A., du Vivier, A. W. P., White, J., Whitehead, S. M., WARIN, A. P., et al. (1995) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb08675.x · Cited by 47
Impact of Gender on Insulin Signaling Pathway in Lacrimal and Salivary Glands of Rats
Rocha, E. M., Hirata, A. E., Carneiro, E. M., et al. (2002) · Endocrine · doi:10.1385/endo:18:2:191 · Cited by 20
Cited by
Akt signalling in health and disease
Hers, I., Vincent, E. E., & Tavaré, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.004 · Cited by 1,239
The mTOR Signalling Pathway in Human Cancer
Pópulo, H., Lopes, J. M., & Soares, P. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13021886 · Cited by 830
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
LoPiccolo, J., Blumenthal, G. M., Bernstein, W. B., & Dennis, P. A. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2007.11.003 · Cited by 801
Immunohistochemical characteristics of melanoma
Ohsie, S. J., Sarantopoulos, G. P., Cochran, A. J., & Binder, S. W. (2008) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2007.00891.x · Cited by 593
Malignant melanoma: genetics and therapeutics in the genomic era
Chin, L., Garraway, L. A., & Fisher, D. E. (2006) · Genes & Development · doi:10.1101/gad.1437206 · Cited by 511
Metadata
- Authors
- Dai, D. L., Martinka, M., & Li, G.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-03-01
- Volume
- 23
- Issue
- 7
- Pages
- 1473-1482
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2129318139
- Cited by
- 318
- References
- 58
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.